← SynDRA
SYN0046495
SynDRA canonical compound SYN0046495 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ABL1 | BCR |
|---|
| Mechanism of action | Bcr-Abl kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ABL1 INHIBITOR
- Bcr-Abl kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- GNF-5
- PMID25656651-COMPOUND-10
- GNF 5
- GNF5
- GNF-5 compound
- RefChem:144085
- -GNF 5
- 3ZUA56XMQQ
- UNII-3ZUA56XMQQ
- MFCD16877246
- MLS003230941
- SCHEMBL924071
- GNF-5?
- GTPL8065
- orb1307410
- SCHEMBL29453036
- EX-A312
- GLXC-05524
- HMS3653H13
- HMS3744C21
- BDBM50328152
- EBC-14022
- s7526
- AKOS022179178
- CCG-268867
- CS-1811
- SB19394
- GNF-5, >=98% (HPLC)
- NCGC00351432-08
- NCGC00351432-12
- AC-32986
- BS-17616
- DA-33596
- HY-15738
- SMR001913506
- G5322
- SW219191-1
- EN300-251361
- F857124
- Z2037279435
Look up SYN0046495 in the interactive SynDRA portal →